| Record Information |
|---|
| Version | 5.0 |
|---|
| Status | Expected but not Quantified |
|---|
| Creation Date | 2012-09-06 15:16:49 UTC |
|---|
| Update Date | 2022-03-07 02:51:38 UTC |
|---|
| HMDB ID | HMDB0014466 |
|---|
| Secondary Accession Numbers | |
|---|
| Metabolite Identification |
|---|
| Common Name | Amitriptyline |
|---|
| Description | Amitriptyline hydrochloride is a dibenzocycloheptene-derivative tricyclic antidepressant (TCA). TCAs are structurally similar to phenothiazines. They contain a tricyclic ring system with an alkyl amine substituent on the central ring. In non-depressed individuals, amitriptyline does not affect mood or arousal, but may cause sedation. In depressed individuals, amitriptyline exerts a positive effect on mood. TCAs are potent inhibitors of serotonin and norepinephrine reuptake. Tertiary amine TCAs, such as amitriptyline, are more potent inhibitors of serotonin reuptake than secondary amine TCAs, such as nortriptyline. TCAs also down-regulate cerebral cortical β-adrenergic receptors and sensitize post-synaptic serotonergic receptors with chronic use. The antidepressant effects of TCAs are thought to be due to an overall increase in serotonergic neurotransmission. TCAs also block histamine-H1 receptors, α1-adrenergic receptors and muscarinic receptors, which accounts for their sedative, hypotensive and anticholinergic effects (e.g. blurred vision, dry mouth, constipation, urinary retention), respectively. See toxicity section below for a complete listing of side effects. Amitriptyline may be used to treat depression, chronic pain (unlabeled use), irritable bowel syndrome (unlabeled use), diabetic neuropathy (unlabeled use), post-traumatic stress disorder (unlabeled use), and for migraine prophylaxis (unlabeled use). |
|---|
| Structure | CN(C)CCC=C1C2=CC=CC=C2CCC2=CC=CC=C12 InChI=1S/C20H23N/c1-21(2)15-7-12-20-18-10-5-3-8-16(18)13-14-17-9-4-6-11-19(17)20/h3-6,8-12H,7,13-15H2,1-2H3 |
|---|
| Synonyms | | Value | Source |
|---|
| 10,11-Dihydro-5-(gamma-dimethylaminopropylidene)-5H-dibenzo(a,D)cycloheptene | ChEBI | | 10,11-Dihydro-N,N-dimethyl-5H-dibenzo(a,D)heptalene-Delta(5),gamma-propylamine | ChEBI | | 3-(10,11-Dihydro-5H-dibenzo(a,D)cyclohepten-5-ylidene)-N,N-dimethyl-1-propanamine | ChEBI | | 3-(10,11-Dihydro-5H-dibenzo[a,D]cyclohepten-5-ylidene)-N,N-dimethylpropan-1-amine | ChEBI | | 5-(3-Dimethylaminopropylidene)-10,11-dihydro-5H-dibenzo(a,D)cycloheptatriene | ChEBI | | 5-(3-Dimethylaminopropylidene)-10,11-dihydro-5H-dibenzo(a,D)cycloheptene | ChEBI | | 5-(gamma-Dimethylaminopropylidene)-5H-dibenzo[a,D][1,4]cycloheptadiene | ChEBI | | Amitriptylin | ChEBI | | Laroxyl | Kegg | | 10,11-Dihydro-5-(g-dimethylaminopropylidene)-5H-dibenzo(a,D)cycloheptene | Generator | | 10,11-Dihydro-5-(γ-dimethylaminopropylidene)-5H-dibenzo(a,D)cycloheptene | Generator | | 10,11-Dihydro-N,N-dimethyl-5H-dibenzo(a,D)heptalene-delta(5),g-propylamine | Generator | | 10,11-Dihydro-N,N-dimethyl-5H-dibenzo(a,D)heptalene-δ(5),γ-propylamine | Generator | | 5-(g-Dimethylaminopropylidene)-5H-dibenzo[a,D][1,4]cycloheptadiene | Generator | | 5-(Γ-dimethylaminopropylidene)-5H-dibenzo[a,D][1,4]cycloheptadiene | Generator | | 10,11-Dihydro-N,N-dimethyl-5H-dibenzo(a,D)heptalene-δ(5),g-propylamine | HMDB | | Amitriprolidine | HMDB | | Amitryptiline | HMDB | | Amitryptyline | HMDB | | Amytriptiline | HMDB | | APS brand OF amitriptyline hydrochloride | HMDB | | Amitriptylin beta | HMDB | | Apo-amitriptyline | HMDB | | Apotex brand OF amitriptyline hydrochloride | HMDB | | Bayer brand OF amitriptyline hydrochloride | HMDB | | Desitin, amitriptylin | HMDB | | Domical | HMDB | | Douglas brand OF amitriptyline hydrochloride | HMDB | | Goldshield brand OF amitriptyline hydrochloride | HMDB | | Merck brand OF amitriptyline hydrochloride | HMDB | | Merck sharp and dohme brand OF amitriptyline embonate | HMDB | | Rodleben brand OF amitriptyline hydrochloride | HMDB | | Saroten | HMDB | | Tryptine | HMDB | | Amitriptylin RPH | HMDB | | Amitrol | HMDB | | Apo amitriptyline | HMDB | | ApoAmitriptyline | HMDB | | Cahill may roberts brand OF amitriptyline hydrochloride | HMDB | | Novoprotect | HMDB | | Rhône poulenc rorer brand OF amitriptyline hydrochloride | HMDB | | Tryptanol | HMDB | | Tryptizol | HMDB | | beta, Amitriptylin | HMDB | | Alphapharm brand OF amitriptyline hydrochloride | HMDB | | Amitrip | HMDB | | Amitriptylin-neuraxpharm | HMDB | | Amitriptylinneuraxpharm | HMDB | | Anapsique | HMDB | | Cahill may roberts brand OF amitriptyline embonate | HMDB | | Damilen | HMDB | | Desitin brand OF amitriptyline hydrochloride | HMDB | | Endep | HMDB | | Hexal brand OF amitriptyline hydrochloride | HMDB | | Krewel brand OF amitriptyline hydrochloride | HMDB | | Protea brand OF amitriptyline hydrochloride | HMDB | | Psicofarma brand OF amitriptyline hydrochloride | HMDB | | RPH, Amitriptylin | HMDB | | Rhône-poulenc rorer brand OF amitriptyline hydrochloride | HMDB | | Roche brand OF amitriptyline hydrochloride | HMDB | | Sarotex | HMDB | | Syneudon | HMDB | | Triptafen | HMDB | | Amineurin | HMDB | | Amitriptylin desitin | HMDB | | Amitriptylin neuraxpharm | HMDB | | Amitriptyline hydrochloride | HMDB | | Amrad brand OF amitriptyline hydrochloride | HMDB | | Betapharm brand OF amitriptyline hydrochloride | HMDB | | DDSA brand OF amitriptyline hydrochloride | HMDB | | Elavil | HMDB | | Lentizol | HMDB | | Lundbeck brand OF amitriptyline hydrochloride | HMDB | | Merck sharp and dohme brand OF amitriptyline hydrochloride | HMDB | | Neuro hexal brand OF amitriptyline hydrochloride | HMDB | | Parke davis brand OF amitriptyline hydrochloride | HMDB | | Zeneca brand OF amitriptyline hydrochloride | HMDB | | Neuraxpharm brand OF amitriptyline hydrochloride | HMDB |
|
|---|
| Chemical Formula | C20H23N |
|---|
| Average Molecular Weight | 277.4033 |
|---|
| Monoisotopic Molecular Weight | 277.183049741 |
|---|
| IUPAC Name | dimethyl(3-{tricyclo[9.4.0.0³,⁸]pentadeca-1(15),3,5,7,11,13-hexaen-2-ylidene}propyl)amine |
|---|
| Traditional Name | amitriptyline |
|---|
| CAS Registry Number | 50-48-6 |
|---|
| SMILES | CN(C)CCC=C1C2=CC=CC=C2CCC2=CC=CC=C12 |
|---|
| InChI Identifier | InChI=1S/C20H23N/c1-21(2)15-7-12-20-18-10-5-3-8-16(18)13-14-17-9-4-6-11-19(17)20/h3-6,8-12H,7,13-15H2,1-2H3 |
|---|
| InChI Key | KRMDCWKBEZIMAB-UHFFFAOYSA-N |
|---|
| Chemical Taxonomy |
|---|
| Description | Belongs to the class of organic compounds known as dibenzocycloheptenes. Dibenzocycloheptenes are compounds containing a dibenzocycloheptene moiety, which consists of two benzene rings connected by a cycloheptene ring. |
|---|
| Kingdom | Organic compounds |
|---|
| Super Class | Benzenoids |
|---|
| Class | Dibenzocycloheptenes |
|---|
| Sub Class | Not Available |
|---|
| Direct Parent | Dibenzocycloheptenes |
|---|
| Alternative Parents | |
|---|
| Substituents | - Dibenzocycloheptene
- Tertiary aliphatic amine
- Tertiary amine
- Organic nitrogen compound
- Organopnictogen compound
- Hydrocarbon derivative
- Organonitrogen compound
- Amine
- Aromatic homopolycyclic compound
|
|---|
| Molecular Framework | Aromatic homopolycyclic compounds |
|---|
| External Descriptors | |
|---|
| Ontology |
|---|
| Physiological effect | Not Available |
|---|
| Disposition | |
|---|
| Process | Not Available |
|---|
| Role | |
|---|
| Physical Properties |
|---|
| State | Solid |
|---|
| Experimental Molecular Properties | | Property | Value | Reference |
|---|
| Melting Point | 196 - 197 °C | Not Available | | Boiling Point | Not Available | Not Available | | Water Solubility | 0.0045 g/L | Not Available | | LogP | 4.9 | Not Available |
|
|---|
| Experimental Chromatographic Properties | Experimental Collision Cross Sections |
|---|
| Predicted Molecular Properties | |
|---|
| Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Retention Times Underivatized| Chromatographic Method | Retention Time | Reference |
|---|
| Measured using a Waters Acquity ultraperformance liquid chromatography (UPLC) ethylene-bridged hybrid (BEH) C18 column (100 mm × 2.1 mm; 1.7 μmparticle diameter). Predicted by Afia on May 17, 2022. Predicted by Afia on May 17, 2022. | 8.55 minutes | 32390414 | | Predicted by Siyang on May 30, 2022 | 11.8187 minutes | 33406817 | | Predicted by Siyang using ReTip algorithm on June 8, 2022 | 2.1 minutes | 32390414 | | AjsUoB = Accucore 150 Amide HILIC with 10mM Ammonium Formate, 0.1% Formic Acid | 41.3 seconds | 40023050 | | Fem_Long = Waters ACQUITY UPLC HSS T3 C18 with Water:MeOH and 0.1% Formic Acid | 1445.1 seconds | 40023050 | | Fem_Lipids = Ascentis Express C18 with (60:40 water:ACN):(90:10 IPA:ACN) and 10mM NH4COOH + 0.1% Formic Acid | 260.1 seconds | 40023050 | | Life_Old = Waters ACQUITY UPLC BEH C18 with Water:(20:80 acetone:ACN) and 0.1% Formic Acid | 175.6 seconds | 40023050 | | Life_New = RP Waters ACQUITY UPLC HSS T3 C18 with Water:(30:70 MeOH:ACN) and 0.1% Formic Acid | 184.1 seconds | 40023050 | | RIKEN = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 127.2 seconds | 40023050 | | Eawag_XBridgeC18 = XBridge C18 3.5u 2.1x50 mm with Water:MeOH and 0.1% Formic Acid | 438.6 seconds | 40023050 | | BfG_NTS_RP1 =Agilent Zorbax Eclipse Plus C18 (2.1 mm x 150 mm, 3.5 um) with Water:ACN and 0.1% Formic Acid | 485.4 seconds | 40023050 | | HILIC_BDD_2 = Merck SeQuant ZIC-HILIC with ACN(0.1% formic acid):water(16 mM ammonium formate) | 611.4 seconds | 40023050 | | UniToyama_Atlantis = RP Waters Atlantis T3 (2.1 x 150 mm, 5 um) with ACN:Water and 0.1% Formic Acid | 1181.7 seconds | 40023050 | | BDD_C18 = Hypersil Gold 1.9µm C18 with Water:ACN and 0.1% Formic Acid | 410.3 seconds | 40023050 | | UFZ_Phenomenex = Kinetex Core-Shell C18 2.6 um, 3.0 x 100 mm, Phenomenex with Water:MeOH and 0.1% Formic Acid | 1277.9 seconds | 40023050 | | SNU_RIKEN_POS = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 266.0 seconds | 40023050 | | RPMMFDA = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 364.0 seconds | 40023050 | | MTBLS87 = Merck SeQuant ZIC-pHILIC column with ACN:Water and :ammonium carbonate | 309.3 seconds | 40023050 | | KI_GIAR_zic_HILIC_pH2_7 = Merck SeQuant ZIC-HILIC with ACN:Water and 0.1% FA | 370.0 seconds | 40023050 | | Meister zic-pHILIC pH9.3 = Merck SeQuant ZIC-pHILIC column with ACN:Water 5mM NH4Ac pH9.3 and 5mM ammonium acetate in water | 7.8 seconds | 40023050 |
Predicted Kovats Retention IndicesUnderivatized |
|---|
| GC-MS Spectra| Spectrum Type | Description | Splash Key | Deposition Date | Source | View |
|---|
| Experimental GC-MS | GC-MS Spectrum - Amitriptyline EI-B (Non-derivatized) | splash10-0a4i-9010000000-2afae55587735e5a8ce1 | 2017-09-12 | HMDB team, MONA, MassBank | View Spectrum | | Experimental GC-MS | GC-MS Spectrum - Amitriptyline EI-B (Non-derivatized) | splash10-0a4i-9010000000-2afae55587735e5a8ce1 | 2018-05-18 | HMDB team, MONA, MassBank | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - Amitriptyline GC-MS (Non-derivatized) - 70eV, Positive | splash10-0a4i-9040000000-fe5eb711e5e29e99efed | 2017-09-01 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - Amitriptyline GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum | | MS | Mass Spectrum (Electron Ionization) | splash10-0a4i-9210000000-989cd234a8cdf04c5f69 | 2014-09-20 | Not Available | View Spectrum |
MS/MS Spectra| Spectrum Type | Description | Splash Key | Deposition Date | Source | View |
|---|
| Experimental LC-MS/MS | LC-MS/MS Spectrum - Amitriptyline LC-ESI-QTOF , positive-QTOF | splash10-05po-5890000000-4cce07a2d07337e4ce90 | 2017-09-14 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Amitriptyline LC-ESI-ITFT , positive-QTOF | splash10-001i-1590000000-35080e23f36a6ed30005 | 2017-09-14 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Amitriptyline LC-ESI-ITFT , positive-QTOF | splash10-004i-0090000000-66d4e2dc0e65719c8949 | 2017-09-14 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Amitriptyline LC-ESI-ITFT , positive-QTOF | splash10-004i-0190000000-18fad36e219aa0091dcf | 2017-09-14 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Amitriptyline LC-ESI-ITFT , positive-QTOF | splash10-05o3-3980000000-bd3bb65e31837e45268f | 2017-09-14 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Amitriptyline LC-ESI-ITFT , positive-QTOF | splash10-0aou-2940000000-c3c71a4ddeb15eb427b4 | 2017-09-14 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Amitriptyline LC-ESI-ITFT , positive-QTOF | splash10-05mo-2930000000-f6bc4a5899aed7b3047e | 2017-09-14 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Amitriptyline LC-ESI-ITFT , positive-QTOF | splash10-0fr6-2930000000-c348567e54820b6ddff3 | 2017-09-14 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Amitriptyline LC-ESI-ITFT , positive-QTOF | splash10-004i-0090000000-fae7f4e9cc1f20e9a2dd | 2017-09-14 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Amitriptyline LC-ESI-ITFT , positive-QTOF | splash10-004i-0190000000-42ecf4fcfbd4bd102322 | 2017-09-14 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Amitriptyline LC-ESI-ITFT , positive-QTOF | splash10-05o3-3980000000-69e1e5d2fdd46de25ba4 | 2017-09-14 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Amitriptyline LC-ESI-ITFT , positive-QTOF | splash10-0aou-2940000000-853a0f18213b600d48ae | 2017-09-14 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Amitriptyline LC-ESI-ITFT , positive-QTOF | splash10-05mo-2930000000-9493535ee63a9a708527 | 2017-09-14 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Amitriptyline LC-ESI-ITFT , positive-QTOF | splash10-0fr6-2930000000-fba97ca65c4bf1940385 | 2017-09-14 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Amitriptyline LC-ESI-ITFT , positive-QTOF | splash10-001i-1690000000-99ea606fc86c8400c4ce | 2017-09-14 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Amitriptyline LC-ESI-QTOF , positive-QTOF | splash10-004i-0090000000-8155764b5e04e44b4ca2 | 2017-09-14 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Amitriptyline LC-ESI-QTOF , positive-QTOF | splash10-004i-0190000000-7e3a5d063f540759d63f | 2017-09-14 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Amitriptyline LC-ESI-QTOF , positive-QTOF | splash10-0apl-0960000000-e35715828f4c02816f19 | 2017-09-14 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Amitriptyline LC-ESI-QTOF , positive-QTOF | splash10-0lfu-0940000000-a6befd2c2f6b01d0c348 | 2017-09-14 | HMDB team, MONA | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Amitriptyline 10V, Positive-QTOF | splash10-004i-0190000000-e92473ae05e0e7ecb6ed | 2016-08-01 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Amitriptyline 20V, Positive-QTOF | splash10-003r-3390000000-db46c53d9e4e8729d7f3 | 2016-08-01 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Amitriptyline 40V, Positive-QTOF | splash10-0006-5940000000-1c8f604ddf2e5e56560e | 2016-08-01 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Amitriptyline 10V, Negative-QTOF | splash10-004i-0090000000-90c019b2f9a1e35d9e6d | 2016-08-03 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Amitriptyline 20V, Negative-QTOF | splash10-004i-1090000000-a8d8a7f9b985c30547f2 | 2016-08-03 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Amitriptyline 40V, Negative-QTOF | splash10-0536-7290000000-3505755fe83fe73e694f | 2016-08-03 | Wishart Lab | View Spectrum |
|
|---|